PBM
Propel Bio Management Portfolio holdings
AUM
$82.4M
This Quarter Return
+28.07%
1 Year Return
+29.32%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$121M
AUM Growth
–
Cap. Flow
+$121M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
71.63%
Holding
34
New
34
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Plains GP Holdings
PAGP
|
$21.9M |
| 2 |
Applied Therapeutics
APLT
|
$18M |
| 3 |
TScan Therapeutics
TCRX
|
$12.2M |
| 4 |
Madrigal Pharmaceuticals
MDGL
|
$6.95M |
| 5 |
Crinetics Pharmaceuticals
CRNX
|
$5.87M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 62.69% |
| 2 | Energy | 18.15% |
| 3 | Technology | 2.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
iShares 0-5 Year Investment Grade Corporate Bond ETF
SLQD
$2.36B
| $598K | 0.5% |
+12,148
| New | +$598K |
|
27
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$29.4B
| $493K | 0.41% |
+4,456
| New | +$493K |
|
28
X4 Pharmaceuticals
XFOR
$70M
| $449K | 0.37% |
+535,000
| New | +$449K |
|
|
CYBN
29
Cybin
CYBN
$142M
| $349K | 0.29% |
+850,000
| New | +$349K |
|
30
SPDR Bloomberg Investment Grade Floating Rate ETF
FLRN
$2.78B
| $283K | 0.24% |
+9,267
| New | +$283K |
|
31
Heron Therapeutics
HRTX
$204M
| $177K | 0.15% |
+104,195
| New | +$177K |
|
32
Agios Pharmaceuticals
AGIO
$2.36B
| $129K | 0.11% |
+5,792
| New | +$129K |
|